{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T14:23:24Z","timestamp":1788963804199,"version":"build-2803163510"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T00:00:00Z","timestamp":1775520000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T00:00:00Z","timestamp":1775520000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Universidad Autonoma Metropolitana"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pharm Res"],"published-print":{"date-parts":[[2026,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Methotrexate (MTX) remains a cornerstone therapy in autoimmune diseases and oncology; however, substantial interindividual variability in efficacy and toxicity persists. While variability in MTX pharmacokinetics (PK) and pharmacodynamics (PD) has been linked to transporters, folate-cycle enzymes, and intracellular polyglutamate accumulation, the contribution of long non-coding RNAs (lncRNAs) as regulatory modifiers of these processes is not yet systematically defined.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To synthesize current evidence on lncRNA-mediated regulation of MTX response and to organize these interactions within a pharmacology-centered mechanistic framework.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A narrative, mechanism-oriented review was conducted integrating preclinical, translational, and computational studies evaluating lncRNA involvement in MTX-related pathways across immune-mediated diseases and cancer.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>lncRNAs were found to intersect with MTX pharmacology across four principal mechanistic nodes: (1) regulation of drug transport and intracellular retention (e.g., modulation of ABC transporters); (2) control of folate-axis targets and compensatory metabolic pathways (e.g., DHFR and TYMS regulation); (3) modulation of adenosine-mediated immunoregulation and NF-\u03baB signaling, with lincRNA-p21 representing the most mechanistically supported example in rheumatoid arthritis; and (4) orchestration of stress-adaptive and survival pathways influencing antifolate resistance (e.g., PI3K-AKT-mTOR and apoptosis networks). However, most evidence derives from in vitro or computational studies, with limited integration of lncRNA perturbation and quantitative PK metrics such as intracellular MTX-polyglutamate levels.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>lncRNAs function as context-dependent modulators of MTX PK\/PD processes rather than primary drug targets. Current evidence is heterogeneous, future studies integrating functional genomics, PK measurements, and prospective clinical validation are required to establish lncRNAs as predictive biomarkers or therapeutic targets in MTX precision pharmacology.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s11095-026-04087-3","type":"journal-article","created":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T16:14:25Z","timestamp":1775578465000},"page":"1343-1355","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Regulatory Roles of Long Non-Coding RNAs in Methotrexate Pharmacology: Mechanistic and Translational Insights"],"prefix":"10.1007","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7365-9023","authenticated-orcid":false,"given":"Carlos A.","family":"Guzm\u00e1n-Mart\u00edn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia Janet","family":"Gonz\u00e1lez-Moyotl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaneli","family":"Ju\u00e1rez-Vicu\u00f1a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael","family":"Bojalil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura Aline","family":"Mart\u00ednez-Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Laura","family":"Arenas-D\u00edaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mart\u00edn","family":"Mart\u00ednez-Rosas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Pe\u00f1a-Pe\u00f1a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel Angel","family":"V\u00e1zquez-Toledo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodrigo","family":"Romero-Nava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rogelio Frank","family":"Jim\u00e9nez-Ortega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Hidalgo-Bravo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael","family":"Vel\u00e1zquez-Cruz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fausto","family":"S\u00e1nchez-Mu\u00f1oz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,7]]},"reference":[{"key":"4087_CR1","doi-asserted-by":"crossref","unstructured":"Cronstein BN. THE MECHANISM OF ACTION OF METHOTREXATE. Vol. 23. 1997. Report.","DOI":"10.1016\/S0889-857X(05)70358-6"},{"key":"4087_CR2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0130078","author":"S Thomas","year":"2015","unstructured":"Thomas S, Fisher KH, Snowden JA, Danson SJ, Brown S, Zeidler MP. Methotrexate is a JAK\/STAT pathway inhibitor. PLoS One. 2015. https:\/\/doi.org\/10.1371\/journal.pone.0130078.","journal-title":"PLoS One"},{"issue":"9","key":"4087_CR3","doi-asserted-by":"publisher","DOI":"10.7759\/CUREUS.29518","volume":"14","author":"KM Hamed","year":"2022","unstructured":"Hamed KM, Dighriri IM, Baomar AF, Alharthy BT, Alenazi FE, Alali GH, et al. Overview of methotrexate toxicity: a comprehensive literature review. Cureus. 2022;14(9):e29518. https:\/\/doi.org\/10.7759\/CUREUS.29518.","journal-title":"Cureus"},{"issue":"9","key":"4087_CR4","doi-asserted-by":"publisher","DOI":"10.3390\/MICROORGANISMS11092342","volume":"11","author":"J Gonz\u00e1lez-Ram\u00edrez","year":"2023","unstructured":"Gonz\u00e1lez-Ram\u00edrez J, Leija-Montoya AG, Seraf\u00edn-Higuera N, Guzm\u00e1n-Mart\u00edn CA, Amezcua-Guerra LM, Olvera-Sandoval C, et al. Increased Expression of lncRNA AC000120.7 and SENP3-EIF4A1 in Patients with Acute Respiratory Distress Syndrome Induced by SARS-CoV-2 Infection: A Pilot Study. Microorganisms. 2023;11(9):2342. https:\/\/doi.org\/10.3390\/MICROORGANISMS11092342.","journal-title":"Microorganisms"},{"key":"4087_CR5","doi-asserted-by":"publisher","unstructured":"Guzm\u00e1n-Mart\u00edn CA, Ju\u00e1rez-Vicu\u00f1a Y, Dom\u00ednguez-L\u00f3pez A, Gonz\u00e1lez-Ram\u00edrez J, Amezcua-Guerra LM, Mart\u00ednez-Mart\u00ednez LA, et al. LncRNAs dysregulation in monocytes from primary antiphospholipid syndrome patients: a bioinformatic and an experimental proof-of-concept approach. Mol Biol Rep. 2022(1). https:\/\/doi.org\/10.1007\/S11033-022-08080-Y.","DOI":"10.1007\/S11033-022-08080-Y"},{"key":"4087_CR6","doi-asserted-by":"publisher","DOI":"10.3389\/FNMOL.2021.714768\/XML","volume":"14","author":"R Policarpo","year":"2021","unstructured":"Policarpo R, Sierksma A, De Strooper B, d\u2019Ydewalle C. From junk to function: LncRNAs in CNS health and disease. Front Mol Neurosci. 2021;14:714768. https:\/\/doi.org\/10.3389\/FNMOL.2021.714768\/XML.","journal-title":"Front Mol Neurosci"},{"issue":"1","key":"4087_CR7","first-page":"73","volume":"90","author":"B Prabhakar","year":"2017","unstructured":"Prabhakar B, Zhong XB, Rasmussen TP. Exploiting Long Noncoding RNAs as Pharmacological Targets to Modulate Epigenetic Diseases. Yale J Biol Med. 2017Mar 1;90(1):73 (PubMed PMID: 28356895).","journal-title":"Yale J Biol Med"},{"key":"4087_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/J.BCP.2021.114567","volume":"189","author":"B Ning","year":"2021","unstructured":"Ning B, Yu AM. RNA therapeutics: from biochemical pharmacology to technology development and clinical applications. Biochem Pharmacol. 2021;189:114567. https:\/\/doi.org\/10.1016\/J.BCP.2021.114567.","journal-title":"Biochem Pharmacol"},{"issue":"2","key":"4087_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/J.NCRNA.2024.01.021","volume":"9","author":"Y Ju\u00e1rez-Vicu\u00f1a","year":"2024","unstructured":"Ju\u00e1rez-Vicu\u00f1a Y, Ruiz-Ojeda D, Gonz\u00e1lez-Ram\u00edrez J, Flores-Balderas X, Springall R, S\u00e1nchez-Mu\u00f1oz F, et al. LncRNA MALAT1 in keratinocyte function: a review of recent advances. Noncoding RNA Res. 2024;9(2):594. https:\/\/doi.org\/10.1016\/J.NCRNA.2024.01.021.","journal-title":"Noncoding RNA Res"},{"issue":"11","key":"4087_CR10","doi-asserted-by":"publisher","first-page":"2947","DOI":"10.1002\/ART.38805","volume":"66","author":"CF Spurlock","year":"2014","unstructured":"Spurlock CF, Tossberg JT, Matlock BK, Olsen NJ, Aune TM. Methotrexate inhibits NF-\u03baB activity via lincRNA-p21 induction. Arthritis Rheumatol. 2014;66(11):2947. https:\/\/doi.org\/10.1002\/ART.38805.","journal-title":"Arthritis Rheumatol"},{"issue":"2","key":"4087_CR11","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1016\/j.bbrc.2017.03.042","volume":"491","author":"C Li","year":"2017","unstructured":"Li C, Gao Y, Li Y, Ding D. TUG1 mediates methotrexate resistance in colorectal cancer via miR-186\/CPEB2 axis. Biochem Biophys Res Commun. 2017;491(2):552\u20137. https:\/\/doi.org\/10.1016\/j.bbrc.2017.03.042.","journal-title":"Biochem Biophys Res Commun"},{"issue":"6","key":"4087_CR12","doi-asserted-by":"publisher","first-page":"3808","DOI":"10.1111\/JCMM.14071","volume":"23","author":"D Xian","year":"2019","unstructured":"Xian D, Zhao Y. LncRNA KCNQ1OT1 enhanced the methotrexate resistance of colorectal cancer cells by regulating miR-760\/PPP1R1B via the cAMP signalling pathway. J Cell Mol Med. 2019;23(6):3808\u201323. https:\/\/doi.org\/10.1111\/JCMM.14071.","journal-title":"J Cell Mol Med"},{"key":"4087_CR13","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-77348-z","author":"T Lan","year":"2024","unstructured":"Lan T, Quan W, Yu DH, Chen X, Wang ZF, Li ZQ. High expression of LncRNA HOTAIR is a risk factor for temozolomide resistance in glioblastoma via activation of the miR-214\/\u03b2-catenin\/MGMT pathway. Sci Rep. 2024. https:\/\/doi.org\/10.1038\/s41598-024-77348-z.","journal-title":"Sci Rep"},{"key":"4087_CR14","doi-asserted-by":"publisher","unstructured":"Friedman B, Cronstein B. Methotrexate mechanism in treatment of rheumatoid arthritis. Joint Bone Spine. 2019(3). https:\/\/doi.org\/10.1016\/j.jbspin.2018.07.004.","DOI":"10.1016\/j.jbspin.2018.07.004"},{"key":"4087_CR15","doi-asserted-by":"publisher","unstructured":"Xiong S, Song D, Xiang Y, Li Y, Zhong Y, Li H, et al. Reactive oxygen species, not Ca2+, mediates methotrexate-induced autophagy and apoptosis in spermatocyte cell line. Basic Clin Pharmacol Toxicol. 2020;126(2):144\u201352. https:\/\/doi.org\/10.1111\/bcpt.13306.","DOI":"10.1111\/bcpt.13306"},{"issue":"1","key":"4087_CR16","doi-asserted-by":"publisher","first-page":"12","DOI":"10.2133\/DMPK.DMPK-13-RV-119","volume":"29","author":"K Inoue","year":"2014","unstructured":"Inoue K, Yuasa H. Molecular basis for pharmacokinetics and pharmacodynamics of methotrexate in rheumatoid arthritis therapy. Drug Metab Pharmacokinet. 2014;29(1):12\u20139. https:\/\/doi.org\/10.2133\/DMPK.DMPK-13-RV-119.","journal-title":"Drug Metab Pharmacokinet"},{"issue":"9","key":"4087_CR17","doi-asserted-by":"publisher","first-page":"2766","DOI":"10.1002\/art.20460","volume":"50","author":"T Dervieux","year":"2004","unstructured":"Dervieux T, Furst D, Lein DO, Capps R, Smith K, Walsh M, et al. Polyglutamation of methotrexate with common polymorphisms in reduced folate carrier, aminoimidazole carboxamide ribonucleotide transformylase, and thymidylate synthase are associated with methotrexate effects in rheumatoid arthritis. Arthritis Rheum. 2004;50(9):2766\u201374. https:\/\/doi.org\/10.1002\/art.20460.","journal-title":"Arthritis Rheum"},{"issue":"6","key":"4087_CR18","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1038\/s41580-022-00566-8","volume":"24","author":"JS Mattick","year":"2023","unstructured":"Mattick JS, Amaral PP, Carninci P, Carpenter S, Chang HY, Chen LL, et al. Long non-coding RNAs: definitions, functions, challenges and recommendations. Nat Rev Mol Cell Biol. 2023;24(6):430\u201347. https:\/\/doi.org\/10.1038\/s41580-022-00566-8.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"4087_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/s41556-019-0311-8","author":"RW Yao","year":"2019","unstructured":"Yao RW, Wang Y, Chen LL. Cellular functions of long noncoding RNAs. Nature Cell Biology. 2019. https:\/\/doi.org\/10.1038\/s41556-019-0311-8.","journal-title":"Nature Cell Biology"},{"key":"4087_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.ncrna.2025.01.004","author":"B Chodurska","year":"2025","unstructured":"Chodurska B, Kunej T. Long non-coding RNAs in humans: Classification, genomic organization and function. Non-coding RNA Research. 2025. https:\/\/doi.org\/10.1016\/j.ncrna.2025.01.004.","journal-title":"Non-coding RNA Research"},{"key":"4087_CR21","doi-asserted-by":"publisher","unstructured":"Statello L, Guo CJ, Chen LL, Huarte M. Gene regulation by long non-coding RNAs and its biological functions. Nature Reviews Molecular Cell Biology. 2021(2). https:\/\/doi.org\/10.1038\/s41580-020-00315-9.","DOI":"10.1038\/s41580-020-00315-9"},{"issue":"2","key":"4087_CR22","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1038\/s41576-020-00295-8","volume":"22","author":"D Wiener","year":"2020","unstructured":"Wiener D, Schwartz S. The epitranscriptome beyond m6A. Nature Reviews Genetics. 2020;22(2):119\u201331. https:\/\/doi.org\/10.1038\/s41576-020-00295-8.","journal-title":"Nature Reviews Genetics"},{"issue":"3","key":"4087_CR23","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/J.JBSPIN.2018.07.004","volume":"86","author":"B Friedman","year":"2018","unstructured":"Friedman B, Cronstein B. Methotrexate mechanism in treatment of rheumatoid arthritis. Joint, bone, spine\u202f: revue du rhumatisme. 2018;86(3):301. https:\/\/doi.org\/10.1016\/J.JBSPIN.2018.07.004.","journal-title":"Joint, bone, spine\u202f: revue du rhumatisme"},{"issue":"10416","key":"4087_CR24","doi-asserted-by":"publisher","first-page":"2019","DOI":"10.1016\/S0140-6736(23)01525-8","volume":"402","author":"A Di Matteo","year":"2023","unstructured":"Di Matteo A, Bathon JM, Emery P. Rheumatoid arthritis. Lancet. 2023;402(10416):2019\u201333. https:\/\/doi.org\/10.1016\/S0140-6736(23)01525-8.","journal-title":"Lancet"},{"issue":"3","key":"4087_CR25","doi-asserted-by":"publisher","DOI":"10.1002\/MCO2.509","volume":"5","author":"Y Gao","year":"2024","unstructured":"Gao Y, Zhang Y, Liu X. Rheumatoid arthritis: pathogenesis and therapeutic advances. MedComm. 2024;5(3):e509. https:\/\/doi.org\/10.1002\/MCO2.509.","journal-title":"MedComm"},{"key":"4087_CR26","doi-asserted-by":"publisher","DOI":"10.3390\/nu17111752","author":"M Pe\u00f1a-Pe\u00f1a","year":"2025","unstructured":"Pe\u00f1a-Pe\u00f1a M, Gonz\u00e1lez-Ram\u00edrez J, Berm\u00fadez-Ben\u00edtez E, S\u00e1nchez-Gloria JL, Amezcua-Guerra LM, Tavera-Alonso C, et al. Regulation of lncRNA NUTM2A-AS1 and CCR3 in the Clinical Response to a Plant-Based Diet in Rheumatoid Arthritis: A Pilot Study. Nutrients. 2025. https:\/\/doi.org\/10.3390\/nu17111752.","journal-title":"Nutrients"},{"key":"4087_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2018.1","author":"JS Smolen","year":"2018","unstructured":"Smolen JS, Aletaha D, Barton A, Burmester GR, Emery P, Firestein GS, et al. Rheumatoid arthritis. Nat Rev Dis Primers. 2018. https:\/\/doi.org\/10.1038\/nrdp.2018.1.","journal-title":"Nat Rev Dis Primers"},{"key":"4087_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(15)00077-7","author":"S Devarakonda","year":"2015","unstructured":"Devarakonda S, Morgensztern D, Govindan R, Lancet Publishing Group. Genomic alterations in lung adenocarcinoma. Lancet Oncol. 2015. https:\/\/doi.org\/10.1016\/S1470-2045(15)00077-7.","journal-title":"Lancet Oncol"},{"issue":"85","key":"4087_CR29","doi-asserted-by":"publisher","DOI":"10.18632\/ONCOTARGET.26217","volume":"9","author":"V Relli","year":"2018","unstructured":"Relli V, Trerotola M, Guerra E, Alberti S. Distinct lung cancer subtypes associate to distinct drivers of tumor progression. Oncotarget. 2018;9(85):35528. https:\/\/doi.org\/10.18632\/ONCOTARGET.26217.","journal-title":"Oncotarget"},{"issue":"6","key":"4087_CR30","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1097\/RTI.0B013E3182688D62","volume":"27","author":"HJ Lee","year":"2012","unstructured":"Lee HJ, Lee CH, Jeong YJ, Chung DH, Goo JM, Park CM, et al. IASLC\/ATS\/ERS international multidisciplinary classification of lung adenocarcinoma: novel concepts and radiologic implications. J Thorac Imaging. 2012;27(6):340\u201353. https:\/\/doi.org\/10.1097\/RTI.0B013E3182688D62.","journal-title":"J Thorac Imaging"},{"issue":"3","key":"4087_CR31","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/CAAC.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209\u201349. https:\/\/doi.org\/10.3322\/CAAC.21660.","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"4087_CR32","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1053\/j.sult.2018.11.009","volume":"40","author":"BD Hutchinson","year":"2019","unstructured":"Hutchinson BD, Shroff GS, Truong MT, Ko JP. Spectrum of lung adenocarcinoma. Semin Ultrasound CT MRI. 2019;40(3):255\u201364. https:\/\/doi.org\/10.1053\/j.sult.2018.11.009.","journal-title":"Semin Ultrasound CT MRI"},{"key":"4087_CR33","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14071759","author":"L Seguin","year":"2022","unstructured":"Seguin L, Durandy M, Feral CC. Lung adenocarcinoma tumor origin: a guide for personalized medicine. Cancers. 2022. https:\/\/doi.org\/10.3390\/cancers14071759.","journal-title":"Cancers"},{"key":"4087_CR34","doi-asserted-by":"publisher","DOI":"10.1186\/s12931-022-02043-4","author":"J Zhuang","year":"2022","unstructured":"Zhuang J, Chen Z, Chen Z, Chen J, Liu M, Xu X, et al. Construction of an immune-related lncRNA signature pair for predicting oncologic outcomes and the sensitivity of immunosuppressor in treatment of lung adenocarcinoma. Respir Res. 2022. https:\/\/doi.org\/10.1186\/s12931-022-02043-4.","journal-title":"Respir Res"},{"key":"4087_CR35","doi-asserted-by":"publisher","DOI":"10.3389\/FCELL.2024.1348894\/FULL","volume":"12","author":"ZY Liu","year":"2024","unstructured":"Liu ZY, Tang JM, Yang MQ, Yang ZH, Xia JZ. The role of LncRNA-mediated autophagy in cancer progression. Front Cell Dev Biol. 2024;12:1348894. https:\/\/doi.org\/10.3389\/FCELL.2024.1348894\/FULL.","journal-title":"Front Cell Dev Biol"},{"issue":"3","key":"4087_CR36","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/CAAC.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Hyuna S, Ferlay J, Siegel RL, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229\u201363. https:\/\/doi.org\/10.3322\/CAAC.21834.","journal-title":"CA Cancer J Clin"},{"issue":"7","key":"4087_CR37","doi-asserted-by":"publisher","DOI":"10.3390\/CANCERS14071732","volume":"14","author":"MS Hossain","year":"2022","unstructured":"Hossain MS, Karuniawati H, Jairoun AA, Urbi Z, Ooi DJ, John A, et al. Colorectal Cancer: A Review of Carcinogenesis, Global Epidemiology, Current Challenges, Risk Factors, Preventive and Treatment Strategies. Cancers. 2022;14(7):1732. https:\/\/doi.org\/10.3390\/CANCERS14071732.","journal-title":"Cancers"},{"issue":"6","key":"4087_CR38","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1007\/S13402-019-00466-8\/FIGURES\/1","volume":"42","author":"L Wei","year":"2019","unstructured":"Wei L, Wang X, Lv L, Zheng Y, Zhang N, Yang M. The emerging role of noncoding RNAs in colorectal cancer chemoresistance. Cell Oncol. 2019;42(6):757\u201368. https:\/\/doi.org\/10.1007\/S13402-019-00466-8\/FIGURES\/1.","journal-title":"Cell Oncol"},{"key":"4087_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/J.PHARMTHERA.2019.107447","volume":"206","author":"S Vodenkova","year":"2020","unstructured":"Vodenkova S, Buchler T, Cervena K, Veskrnova V, Vodicka P, Vymetalkova V. 5-fluorouracil and other fluoropyrimidines in colorectal cancer: past, present and future. Pharmacol Ther. 2020;206:107447. https:\/\/doi.org\/10.1016\/J.PHARMTHERA.2019.107447.","journal-title":"Pharmacol Ther"},{"issue":"2","key":"4087_CR40","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/J.YEXCR.2016.12.003","volume":"350","author":"K Wu","year":"2017","unstructured":"Wu K, Liang WC, Feng L, Pang J, Waye MMY, Zhang JF, et al. H19 mediates methotrexate resistance in colorectal cancer through activating Wnt\/\u03b2-catenin pathway. Exp Cell Res. 2017;350(2):312\u20137. https:\/\/doi.org\/10.1016\/J.YEXCR.2016.12.003. (PubMed PMID: 27919747).","journal-title":"Exp Cell Res"},{"issue":"4","key":"4087_CR41","doi-asserted-by":"publisher","DOI":"10.1002\/MCO2.308","volume":"4","author":"Z Ji","year":"2023","unstructured":"Ji Z, Shen J, Lan Y, Yi Q, Liu H. Targeting signaling pathways in osteosarcoma: mechanisms and clinical studies. MedComm (Beijing). 2023;4(4):e308. https:\/\/doi.org\/10.1002\/MCO2.308.","journal-title":"MedComm (Beijing)"},{"issue":"27","key":"4087_CR42","doi-asserted-by":"publisher","first-page":"3029","DOI":"10.1200\/JCO.2014.59.4895\/ASSET\/9D5BD968-520F-4A0E-8934-DA8ADC9C1617\/ASSETS\/GRAPHIC\/ZLJ02715-5266-T01.JPEG","volume":"33","author":"MS Isakoff","year":"2015","unstructured":"Isakoff MS, Bielack SS, Meltzer P, Gorlick R. Osteosarcoma: current treatment and a collaborative pathway to success. J Clin Oncol. 2015;33(27):3029\u201335. https:\/\/doi.org\/10.1200\/JCO.2014.59.4895\/ASSET\/9D5BD968-520F-4A0E-8934-DA8ADC9C1617\/ASSETS\/GRAPHIC\/ZLJ02715-5266-T01.JPEG.","journal-title":"J Clin Oncol"},{"issue":"1","key":"4087_CR43","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1002\/IJC.24320","volume":"125","author":"L Mirabello","year":"2009","unstructured":"Mirabello L, Troisi RJ, Savage SA. International osteosarcoma incidence patterns in children and adolescents, middle ages and elderly persons. Int J Cancer. 2009;125(1):229\u201334. https:\/\/doi.org\/10.1002\/IJC.24320.","journal-title":"Int J Cancer"},{"issue":"2","key":"4087_CR44","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1200\/JCO.2017.75.1743","volume":"36","author":"JS Whelan","year":"2018","unstructured":"Whelan JS, Davis LE. Osteosarcoma, chondrosarcoma, and chordoma. J Clin Oncol. 2018;36(2):188\u201393. https:\/\/doi.org\/10.1200\/JCO.2017.75.1743.","journal-title":"J Clin Oncol"},{"issue":"11","key":"4087_CR45","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1038\/nrc3838","volume":"11","author":"M Kansara","year":"2014","unstructured":"Kansara M, Teng MW, Smyth MJ, Thomas DM. Translational biology of osteosarcoma. Nat Rev Cancer. 2014;11(11):722\u201335. https:\/\/doi.org\/10.1038\/nrc3838.","journal-title":"Nat Rev Cancer"},{"issue":"6","key":"4087_CR46","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1586\/ECP.11.57","volume":"6","author":"D Lev\u00eaque","year":"2011","unstructured":"Lev\u00eaque D, Santucci R, Gourieux B, Herbrecht R. Pharmacokinetic drug-drug interactions with methotrexate in oncology. Expert Rev Clin Pharmacol. 2011;6(6):743\u201350. https:\/\/doi.org\/10.1586\/ECP.11.57.","journal-title":"Expert Rev Clin Pharmacol"},{"issue":"4","key":"4087_CR47","doi-asserted-by":"publisher","DOI":"10.1096\/FJ.202401039RR","volume":"39","author":"P Drago","year":"2025","unstructured":"Drago P, Bookey N, Leung KY, Henry M, Meleady P, Greene NDE, et al. DHFR2 RNA directly regulates dihydrofolate reductase and its expression level impacts folate one carbon metabolism. FASEB J. 2025;(4):e70391. https:\/\/doi.org\/10.1096\/FJ.202401039RR.","journal-title":"FASEB J"},{"key":"4087_CR48","doi-asserted-by":"publisher","unstructured":"McLendon R, Friedman A, Bigner D, Van Meir EG, Brat DJ, Mastrogianakis GM, et al. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature. 2008Oct 23;455(7216):1061\u20138.\u00a0https:\/\/doi.org\/10.1038\/NATURE07385. (PubMed PMID: 18772890).","DOI":"10.1038\/NATURE07385"},{"issue":"8","key":"4087_CR49","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1093\/NEUONC\/NOAB106","volume":"8","author":"DN Louis","year":"2021","unstructured":"Louis DN, Perry A, Wesseling P, Brat DJ, Cree IA, Figarella-Branger D, et al. The 2021 WHO classification of tumors of the central nervous system: a summary. Neuro Oncol. 2021;8(8):1231\u201351. https:\/\/doi.org\/10.1093\/NEUONC\/NOAB106.","journal-title":"Neuro Oncol"},{"issue":"10","key":"4087_CR50","doi-asserted-by":"publisher","DOI":"10.3390\/CANCERS14102412","volume":"14","author":"S Grochans","year":"2022","unstructured":"Grochans S, Cybulska AM, Simi\u0144ska D, Korbecki J, Kojder K, Chlubek D, et al. Epidemiology of glioblastoma multiforme\u2013literature review. Cancers (Basel). 2022;(10):2412. https:\/\/doi.org\/10.3390\/CANCERS14102412.","journal-title":"Cancers (Basel)"},{"issue":"1","key":"4087_CR51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/S41421-022-00508-W","volume":"1","author":"Y Dang","year":"2022","unstructured":"Dang Y, Zhou D, Du X, Zhao H, Lee CH, Yang J, et al. Molecular mechanism of substrate recognition by folate transporter SLC19A1. Cell Discov. 2022;1(1):1\u201311. https:\/\/doi.org\/10.1038\/S41421-022-00508-W.","journal-title":"Cell Discov"},{"key":"4087_CR52","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.920926","author":"P Xie","year":"2022","unstructured":"Xie P, Yan H, Gao Y, Li X, Zhou DB, Liu ZQ. Construction of m6A-related lncRNA prognostic signature model and immunomodulatory effect in glioblastoma multiforme. Front Oncol. 2022. https:\/\/doi.org\/10.3389\/fonc.2022.920926.","journal-title":"Front Oncol"},{"issue":"3","key":"4087_CR53","doi-asserted-by":"publisher","first-page":"1492","DOI":"10.18632\/AGING.203889","volume":"14","author":"CQ Liu","year":"2022","unstructured":"Liu CQ, Xia QD, Sun JX, Xu JZ, Lu JL, Liu Z, et al. Identification and validation of a twelve immune infiltration-related lncRNA prognostic signature for bladder cancer. Aging. 2022;14(3):1492\u2013507. https:\/\/doi.org\/10.18632\/AGING.203889.","journal-title":"Aging"},{"key":"4087_CR54","unstructured":"Liu J, Liu Y, Gao F, Zhang J, Pan J, Liu Y, et al. Comprehensive study of a novel immune-related lncRNA for prognosis and drug treatment of cervical squamous cell carcinoma. Am J Transl Res [Internet]. 2021. Report. Available from: http:\/\/www.gen-"},{"key":"4087_CR55","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-022-02762-0","author":"X Liu","year":"2022","unstructured":"Liu X, Cheng W, Li H, Song Y. Identification and validation of cuproptosis-related LncRNA signatures as a novel prognostic model for head and neck squamous cell cancer. Cancer Cell Int. 2022. https:\/\/doi.org\/10.1186\/s12935-022-02762-0.","journal-title":"Cancer Cell Int"},{"issue":"55","key":"4087_CR56","doi-asserted-by":"publisher","first-page":"93476","DOI":"10.18632\/ONCOTARGET.19281","volume":"8","author":"C Li","year":"2017","unstructured":"Li C, Liang G, Yang S, Sui J, Yao W, Shen X, et al. Dysregulated lncRNA-UCA1 contributes to the progression of gastric cancer through regulation of the PI3K-Akt-mTOR signaling pathway. Oncotarget. 2017;8(55):93476\u201391. https:\/\/doi.org\/10.18632\/ONCOTARGET.19281.","journal-title":"Oncotarget"},{"key":"4087_CR57","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/J.YJMCC.2014.08.009","volume":"76","author":"S Ounzain","year":"2014","unstructured":"Ounzain S, Pezzuto I, Micheletti R, Burdet F, Sheta R, Nemir M, et al. Functional importance of cardiac enhancer-associated noncoding RNAs in heart development and disease. J Mol Cell Cardiol. 2014;76:55. https:\/\/doi.org\/10.1016\/J.YJMCC.2014.08.009.","journal-title":"J Mol Cell Cardiol"},{"issue":"1","key":"4087_CR58","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-98578-9","volume":"15","author":"R Xu","year":"2025","unstructured":"Xu R, Sun Y, Tian F, Zhao M. LncRNA NEAT1 sponges miR-214-3p to promote osteoblast differentiation through regulating the PI3K\/AKT\/mTOR pathway in aortic valve calcification. Scientific Reports 2025 15:1. 2025;15(1):13665. https:\/\/doi.org\/10.1038\/s41598-025-98578-9.","journal-title":"Scientific Reports 2025 15:1"},{"key":"4087_CR59","doi-asserted-by":"publisher","DOI":"10.3390\/biom9110691","author":"IO Sherif","year":"2019","unstructured":"Sherif IO, Al-Shaalan NH, Sabry D. Ginkgo biloba extract alleviates methotrexate-induced renal injury: new impact on pi3k\/akt\/mtor signaling and malat1 expression. Biomolecules. 2019. https:\/\/doi.org\/10.3390\/biom9110691.","journal-title":"Biomolecules"},{"issue":"2","key":"4087_CR60","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/J.APSB.2020.10.001","volume":"11","author":"Y Chen","year":"2021","unstructured":"Chen Y, Li Z, Chen X, Zhang S. Long non-coding RNAs: from disease code to drug role. Acta Pharm Sin B. 2021;11(2):340\u201354. https:\/\/doi.org\/10.1016\/J.APSB.2020.10.001.","journal-title":"Acta Pharm Sin B"},{"issue":"1","key":"4087_CR61","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/J.APSB.2019.09.011","volume":"10","author":"Y Wang","year":"2020","unstructured":"Wang Y, Fang Z, Hong M, Yang D, Xie W. Long-noncoding RNAs (lncRNAs) in drug metabolism and disposition, implications in cancer chemo-resistance. Acta Pharm Sin B. 2020;10(1):105\u201312. https:\/\/doi.org\/10.1016\/J.APSB.2019.09.011.","journal-title":"Acta Pharm Sin B"}],"container-title":["Pharmaceutical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11095-026-04087-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11095-026-04087-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11095-026-04087-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T15:30:34Z","timestamp":1781537434000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11095-026-04087-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,7]]},"references-count":61,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["4087"],"URL":"https:\/\/doi.org\/10.1007\/s11095-026-04087-3","relation":{},"ISSN":["0724-8741","1573-904X"],"issn-type":[{"value":"0724-8741","type":"print"},{"value":"1573-904X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,7]]},"assertion":[{"value":"2 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}